Evaluation of the Use of the Renuvion APR System in the Labia

Last updated: July 2, 2024
Sponsor: Apyx Medical
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

Renuvion APR System

Clinical Study ID

NCT05323630
APX-22-02
  • Ages 35-70
  • Female
  • Accepts Healthy Volunteers

Study Summary

Labiaplasty is a procedure aimed at reducing lax or loose skin in the labia majora and/or minora due to childbirth, trauma, aging, genetics, or congenital disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Female subjects, ages 35 - 70 years old.

  • ASA Physical Status Classification System Class I and Class II subjects.

  • Labial protrusion Class II and Class III (MOTAKEF scale)12.

  • Females who do not desire traditional invasive surgery.

  • Understands and accepts the obligation not to undergo any other procedures ortreatments in the areas to be treated during study participation.

  • Absence of physical conditions unacceptable to the investigator.

  • Females of childbearing potential who are sexually active must be willing to use anapproved method of birth control during study participation.

  • Willing and able to comply with protocol requirements, including study-requiredimages/photos, assessments/measurements, and returning for follow-up visits.

  • Willing to release rights for the use of study photos, including in publication.

  • Able to read, understand, sign, and date the informed consent.

Exclusion

Exclusion Criteria:

  • Labial protrusion Class I (MOTAKEF scale).

  • Subjects presenting with ASA Physical Status Classification System Classes III orhigher.

  • Pregnant, lactating, or plans to become pregnant during study participation.

  • Known hypersensitivity or allergy to tumescent anesthetic (lidocaine/ epinephrine).

  • Previous treatment in the study treatment area.

  • Active systemic or local skin disease that may alter wound healing.

  • Significant or uncontrolled medical condition that in the opinion of theinvestigator participation in the study may compromise the patient's health.

  • Known susceptibility to keloid formation or hypertrophic scarring.

  • Cancerous or pre-cancerous lesions in the area to be treated.

  • Possesses a surgically implanted electronic device (i.e., pacemaker).

  • Serious mental health illness such as dementia or schizophrenia; psychiatrichospitalization in the past two years.

  • Participation in any other investigational study within 30 days prior to consent andthroughout study participation.

  • Subject who, in the opinion of the investigator, is not an appropriate candidate forthe study.

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Renuvion APR System
Phase:
Study Start date:
April 19, 2023
Estimated Completion Date:
April 23, 2024

Study Description

While traditional surgical procedures have been associated with complications such as dehiscence, hematoma, flap necrosis, narrowed introitus, and pain and asymmetry, correction with RF energy has shown minimal complication rates with high patient satisfaction. This study aims to evaluate the use of the Renuvion APR System for use as a minimally invasive alternative to surgical labiaplasty.

Connect with a study center

  • Allison Plastic Martinez

    Washington, District of Columbia 20037
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.